131 related articles for article (PubMed ID: 11828438)
1. Manumycin A and its analogues are irreversible inhibitors of neutral sphingomyelinase.
Arenz C; Thutewohl M; Block O; Waldmann H; Altenbach HJ; Giannis A
Chembiochem; 2001 Feb; 2(2):141-3. PubMed ID: 11828438
[No Abstract] [Full Text] [Related]
2. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase.
Arenz C; Gartner M; Wascholowski V; Giannis A
Bioorg Med Chem; 2001 Nov; 9(11):2901-4. PubMed ID: 11597471
[TBL] [Abstract][Full Text] [Related]
3. Macquarimicin A inhibits membrane-bound neutral sphingomyelinase from rat brain.
Tanaka M; Nara F; Yamasato Y; Masuda-Inoue S; Doi-Yoshioka H; Kumakura S; Enokita R; Ogita T
J Antibiot (Tokyo); 1999 Jul; 52(7):670-3. PubMed ID: 10513848
[No Abstract] [Full Text] [Related]
4. Biological evaluation of sphingomyelin analogues as inhibitors of sphingomyelinase.
Taguchi M; Goda K; Sugimoto K; Akama T; Yamamoto K; Suzuki T; Tomishima Y; Nishiguchi M; Arai K; Takahashi K; Kobori T
Bioorg Med Chem Lett; 2003 Nov; 13(21):3681-4. PubMed ID: 14552757
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of a difluoromethylene analogue of sphingomyelin as an inhibitor of sphingomyelinase.
Yokomatsu T; Takechi H; Akiyama T; Shibuya S; Kominato T; Soeda S; Shimeno H
Bioorg Med Chem Lett; 2001 May; 11(10):1277-80. PubMed ID: 11392536
[TBL] [Abstract][Full Text] [Related]
6. Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells.
Kouchi H; Nakamura K; Fushimi K; Sakaguchi M; Miyazaki M; Ohe T; Namba M
Biochem Biophys Res Commun; 1999 Nov; 264(3):915-20. PubMed ID: 10544030
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of non-competitive inhibitors of sphingomyelinases with significant activity.
Yokomatsu T; Murano T; Akiyama T; Koizumi J; Shibuya S; Tsuji Y; Soeda S; Shimeno H
Bioorg Med Chem Lett; 2003 Jan; 13(2):229-36. PubMed ID: 12482429
[TBL] [Abstract][Full Text] [Related]
8. Sphingomyelin analogues as inhibitors of sphingomyelinase.
Taguchi M; Sugimoto K; Goda K; Akama T; Yamamoto K; Suzuki T; Tomishima Y; Nishiguchi M; Arai K; Takahashi K; Kobori T
Bioorg Med Chem Lett; 2003 Jun; 13(12):1963-6. PubMed ID: 12781174
[TBL] [Abstract][Full Text] [Related]
9. Manumycin inhibits cell proliferation and the Ras signal transduction pathway in human hepatocellular carcinoma cells.
Zhou JM; Zhu XF; Pan QC; Liao DF; Li ZM; Liu ZC
Int J Mol Med; 2003 Jun; 11(6):767-71. PubMed ID: 12736720
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor.
Hu W; Wu W; Yeung SC; Freedman RS; Kavanagh JJ; Verschraegen CF
Anticancer Res; 2002; 22(2A):665-72. PubMed ID: 12014635
[TBL] [Abstract][Full Text] [Related]
11. Akt-dependent antiapoptotic action of insulin is sensitive to farnesyltransferase inhibitor.
Park D; Pandey SK; Maksimova E; Kole S; Bernier M
Biochemistry; 2000 Oct; 39(41):12513-21. PubMed ID: 11027130
[TBL] [Abstract][Full Text] [Related]
12. Manumycin enhances the cytotoxic effect of paclitaxel on anaplastic thyroid carcinoma cells.
Yeung SC; Xu G; Pan J; Christgen M; Bamiagis A
Cancer Res; 2000 Feb; 60(3):650-6. PubMed ID: 10676649
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of three novel scyphostatin analogues as neutral sphingomyelinase inhibitors.
Pitsinos EN; Wascholowski V; Karaliota S; Rigou C; Couladouros EA; Giannis A
Chembiochem; 2003 Nov; 4(11):1223-5. PubMed ID: 14613115
[No Abstract] [Full Text] [Related]
14. Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol.
MartÃn SF; Navarro F; Forthoffer N; Navas P; Villalba JM
J Bioenerg Biomembr; 2001 Apr; 33(2):143-53. PubMed ID: 11456220
[TBL] [Abstract][Full Text] [Related]
15. Sphingolactones: selective and irreversible inhibitors of neutral sphingomyelinase.
Wascholowski V; Giannis A
Angew Chem Int Ed Engl; 2006 Jan; 45(5):827-30. PubMed ID: 16365835
[No Abstract] [Full Text] [Related]
16. Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells.
Di Paolo A; Danesi R; Nardini D; Bocci G; Innocenti F; Fogli S; Barachini S; Marchetti A; Bevilacqua G; Del Tacca M
Br J Cancer; 2000 Feb; 82(4):905-12. PubMed ID: 10732765
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells.
Di Paolo A; Danesi R; Caputo S; Macchia M; Lastella M; Boggi U; Mosca F; Marchetti A; Del Tacca M
Br J Cancer; 2001 Jun; 84(11):1535-43. PubMed ID: 11384105
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: selective inhibition of macrophage localization.
Sonoda K; Sakamoto T; Yoshikawa H; Ashizuka S; Ohshima Y; Kishihara K; Nomoto K; Ishibashi T; Inomata H
Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2245-51. PubMed ID: 9804132
[TBL] [Abstract][Full Text] [Related]
19. Development of carbohydrate-derived inhibitors of acid sphingomyelinase.
Roth AG; Redmer S; Arenz C
Bioorg Med Chem; 2010 Jan; 18(2):939-44. PubMed ID: 20005726
[TBL] [Abstract][Full Text] [Related]
20. Farnesyltransferase inhibitors reduce Ras activation and ameliorate acetaminophen-induced liver injury in mice.
Saha B; Nandi D
Hepatology; 2009 Nov; 50(5):1547-57. PubMed ID: 19739265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
